Atlas Trials

Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.

Clinical trial NCT07758270 · RECRUITING

Trial details

NCT number
NCT07758270
Sponsor
Washington University School of Medicine
Status
RECRUITING
Study type
OBSERVATIONAL
Multiple Sclerosis (MS) - Relapsing-remitting
Start date
2026-08-15
Primary completion
2029-08-15
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.